{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:52:22Z","timestamp":1780368742279,"version":"3.54.1"},"reference-count":63,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Metabolic syndrome (MS) constitutes an important source of cardiovascular- and cancer-related morbidity and mortality in the general population. Limited information is available on whether these findings can be directly extrapolated to liver recipients. This study aimed to investigate the impact of post-transplant MS present 1 year after liver transplantation on survival rates, risk of major cardiovascular events (CVEs), and de novo malignancies. Methods: Adult deceased-liver-donor recipients who underwent transplantation in our centre between 2010 and 2019 and reached at least 1 year of post-transplantation follow-up were eligible. Results: Of 259 enrolled patients, 20% developed post-transplant MS 1 year after the procedure. The presence of post-transplant MS at 1 year did not affect all-cause mortality (p = 0.144) and risk of de novo malignancies (p = 0.198) in liver recipients. However, it was associated with an overall and time-dependent increase in the risk of major CVEs (p &lt; 0.001). MASH aetiology of liver disease, pre-existing major CVEs, and development of de novo malignancy were independent predictors of all-cause mortality in liver recipients. Conclusions: New onset MS exerts a wide-ranging effect on the post-transplant prognosis of liver recipients. Obtaining optimal control over all modifiable metabolic risk factors is central to improving long-term outcomes in this population.<\/jats:p>","DOI":"10.3390\/jcm13061719","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T04:25:15Z","timestamp":1710735915000},"page":"1719","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["De Novo Metabolic Syndrome 1 Year after Liver Transplantation and Its Association with Mid- and Long-Term Morbidity and Mortality in Liver Recipients"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5820-0548","authenticated-orcid":false,"given":"Kinga","family":"Czarnecka","sequence":"first","affiliation":[{"name":"Department of Transplant Medicine, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3938-6874","authenticated-orcid":false,"given":"Paulina","family":"Czarnecka","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Tronina","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2956-3056","authenticated-orcid":false,"given":"Teresa","family":"B\u0105czkowska","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4798-1497","authenticated-orcid":false,"given":"Magdalena","family":"Durlik","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SLA.0000000000002650","article-title":"No Gains in Long-term Survival after Liver Transplantation over the Past Three Decades","volume":"269","author":"Rana","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","article-title":"Evolution of causes and risk factors for mortality post-liver transplant: Results of the NIDDK long-term follow-up study","volume":"10","author":"Watt","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/lt.21952","article-title":"Posttransplant metabolic syndrome: An epidemic waiting to happen","volume":"15","author":"Pagadala","year":"2009","journal-title":"Liver Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/lt.24137","article-title":"Cardiovascular disease after liver transplantation: When, what, and who is at risk","volume":"21","author":"Fussner","year":"2015","journal-title":"Liver Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/lt.23531","article-title":"Burden of de novo malignancy in the liver transplant recipient","volume":"18","author":"Chandok","year":"2012","journal-title":"Liver Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death","volume":"49","author":"Gami","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.trre.2017.03.004","article-title":"Risk factors for metabolic syndrome after liver transplantation: A systematic review and meta-analysis","volume":"32","author":"Thoefner","year":"2018","journal-title":"Transplant. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/lt.23508","article-title":"Is liver transplantation a risk factor for cardiovascular disease? a meta-analysis of observational studies","volume":"18","author":"Madhwal","year":"2012","journal-title":"Liver Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/LVT.0000000000000004","article-title":"De novo metabolic syndrome after liver transplantation: A meta-analysis on cumulative incidence, risk factors, and outcomes","volume":"29","author":"Lim","year":"2023","journal-title":"Liver Transplant."},{"key":"ref_10","first-page":"586","article-title":"Metabolic syndrome before liver transplantation: Does it have an impact on post liver transplantation outcomes?","volume":"114","author":"Puchades","year":"2022","journal-title":"Rev. Espa\u00f1ola Enfermedades Dig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The Metabolic Syndrome and Cardiovascular Risk","volume":"56","author":"Mottillo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00007890-200203270-00012","article-title":"Cardiovascular morbidity and mortality after orthotopic liver transplantation","volume":"73","author":"Johnston","year":"2002","journal-title":"Transplantation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/lt.21943","article-title":"Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis","volume":"15","author":"Malik","year":"2009","journal-title":"Liver Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.trsl.2016.12.004","article-title":"The metabolic syndrome and chronic kidney disease","volume":"183","author":"Zhang","year":"2017","journal-title":"Transl. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"904001","DOI":"10.3389\/fendo.2022.904001","article-title":"Metabolic Syndrome-Related Kidney Injury: A Review and Update","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/TP.0000000000003998","article-title":"De Novo Malignancy after Liver Transplantation: Risk Assessment, Prevention, and Management\u2014Guidelines from the ILTS-SETH Consensus Conference","volume":"106","author":"Colmenero","year":"2022","journal-title":"Transplantation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","author":"Merli","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index","volume":"6","author":"Feng","year":"2006","journal-title":"Am. J. Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref_21","unstructured":"(2023, March 15). The Polish Transplant Society. Available online: https:\/\/p-t-t.org\/artykul\/zalecenia-dotyczace-leczenia-immunosupresyjnego-po-przeszczepieniu-narzadow-unaczynionych."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/liv.12582","article-title":"Appraising cardiac dysfunction in liver transplantation: An ongoing challenge","volume":"35","author":"Zaky","year":"2015","journal-title":"Liver Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/hep.31647","article-title":"Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions","volume":"73","author":"Barman","year":"2021","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1600-6143.2008.02276.x","article-title":"Predictive Value of Dobutamine Stress Echocardiography for Coronary Artery Disease Detection in Liver Transplant Candidates","volume":"8","author":"Harinstein","year":"2008","journal-title":"Am. J. Transplant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1161\/CIR.0000000000001104","article-title":"Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association","volume":"146","author":"Cheng","year":"2022","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4254\/wjh.v10.i11.877","article-title":"Cardiac stress testing and coronary artery disease in liver transplantation candidates: Meta-analysis","volume":"10","author":"Soldera","year":"2018","journal-title":"World J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MOT.0000000000000614","article-title":"Understanding and managing cardiovascular outcomes in liver transplant recipients","volume":"24","author":"Izzy","year":"2019","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Yukino-Iwashita, M., Nagatomo, Y., Kawai, A., Taruoka, A., Yumita, Y., Kagami, K., Yasuda, R., Toya, T., Ikegami, Y., and Masaki, N. (2022). Short-Chain Fatty Acids in Gut\u2013Heart Axis: Their Role in the Pathology of Heart Failure. J. Pers. Med., 12.","DOI":"10.3390\/jpm12111805"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2013.09.023","article-title":"Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis","volume":"12","author":"Wang","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cgh.2021.11.014","article-title":"Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review","volume":"21","author":"Yong","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"106752","DOI":"10.1016\/j.ijsu.2022.106752","article-title":"Clinical evidence of outcomes following liver transplantation in patients with nonalcoholic steatohepatitis: An updated meta-analysis and systematic review","volume":"104","author":"Zhou","year":"2022","journal-title":"Int. J. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1600-6143.2009.02590.x","article-title":"Outcome After Liver Transplantation for NASH Cirrhosis","volume":"9","author":"Malik","year":"2009","journal-title":"Am. J. Transplant."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1097\/TP.0000000000004208","article-title":"Relatively Poor Long-term Outcomes Following Liver Transplantation for NASH in the United States","volume":"106","author":"Jamil","year":"2022","journal-title":"Transplantation"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Nagai, S., Collins, K., Chau, L.C., Safwan, M., Rizzari, M., Yoshida, A., Abouljoud, M.S., and Moonka, D. (2019). Inferior Liver Transplant Outcomes in Patients with Nonalcoholic Steatohepatitis. SSRN Electron. J.","DOI":"10.2139\/ssrn.3309408"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Zhan, X., and Zhang, Y. Outcomes of Non-Alcoholic Steatohepatitis Patients After Liver Transplantation: A Systematic Review and Meta-Analysis. Hepat. Mon., 2019. in press.","DOI":"10.5812\/hepatmon.82336"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21037\/tgh-20-236","article-title":"Implications of pre-transplant sarcopenia and frailty in patients with non-alcoholic steatohepatitis and alcoholic liver disease","volume":"7","author":"Redman","year":"2022","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0000000000001109","article-title":"Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality","volume":"53","author":"Aby","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100881","DOI":"10.1016\/j.jhepr.2023.100881","article-title":"Cirrhosis-related sarcopenia may not resolve after liver transplantation","volume":"5","author":"Brown","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/cld.1000","article-title":"Nonalcoholic Steatohepatitis, Sarcopenia, and Liver Transplantation","volume":"17","author":"Bhanji","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/lt.25346","article-title":"Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease","volume":"25","author":"Bhanji","year":"2019","journal-title":"Liver Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1111\/ajt.14675","article-title":"Physical frailty after liver transplantation","volume":"18","author":"Lai","year":"2018","journal-title":"Am. J. Transplant."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s11739-023-03339-z","article-title":"Sarcopenia, a condition shared by various diseases: Can we alleviate or delay the progression?","volume":"18","author":"Tarantino","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/17474124.2022.2137488","article-title":"Metabolic syndrome, hepatic fibrosis, and steatosis diagnosed by liver stiffness measurement and controlled attenuation parameter after liver transplantation: The impact on long-term survival","volume":"16","author":"Eshraghian","year":"2022","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1097\/TP.0000000000002317","article-title":"Recurrent or de Novo Allograft Steatosis and Long-term Outcomes after Liver Transplantation","volume":"103","author":"Narayanan","year":"2019","journal-title":"Transplantation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.23936","article-title":"Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: Natural history based on liver biopsy analysis","volume":"20","author":"Vallin","year":"2014","journal-title":"Liver Transplant."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"103933","DOI":"10.1016\/j.amsu.2022.103933","article-title":"Gender specific survival rates after deceased donor liver transplantation: A retrospective cohort","volume":"79","author":"Gabbay","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/liv.14510","article-title":"Influence of donor and recipient gender on liver transplantation outcomes in Europe","volume":"40","author":"Germani","year":"2020","journal-title":"Liver Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0030-1262902","article-title":"Metabolic Implications of Menopause","volume":"28","author":"Polotsky","year":"2010","journal-title":"Semin. Reprod. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/lt.22468","article-title":"Cumulative risk of cardiovascular events after orthotopic liver transplantation","volume":"18","author":"Albeldawi","year":"2012","journal-title":"Liver Transplant."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.21126","article-title":"Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events","volume":"13","author":"Laryea","year":"2007","journal-title":"Liver Transplant."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.22198","article-title":"Metabolic syndrome in liver transplant recipients: Prevalence, risk factors, and association with cardiovascular events","volume":"17","author":"Laish","year":"2011","journal-title":"Liver Transplant."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0002-9610(02)00826-7","article-title":"Immunosuppression impact on long-term cardiovascular complications after liver transplantation","volume":"183","author":"Rabkin","year":"2002","journal-title":"Am. J. Surg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"8753","DOI":"10.3748\/wjg.v21.i29.8753","article-title":"Neoplastic disease after liver transplantation: Focus on de novo neoplasms","volume":"21","author":"Burra","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/dc12-0336","article-title":"Metabolic Syndrome and Risk of Cancer","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41416-020-1012-6","article-title":"Association of obesity status and metabolic syndrome with site-specific cancers: A population-based cohort study","volume":"123","author":"Cao","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/1940-6207.CAPR-20-0161","article-title":"Long-Term Glucocorticoid Use and Cancer Risk: A Population-Based Cohort Study in South Korea","volume":"13","author":"Oh","year":"2020","journal-title":"Cancer Prev. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clgc.2023.08.007","article-title":"Chronic Glucocorticoid Use and Risk for Advanced Prostate Cancer at Presentation: A SEER-Medicare Cohort Study","volume":"22","author":"Singh","year":"2023","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","article-title":"Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit","volume":"10","author":"Collett","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zwart, E.S., Y\u00fcksel, E., Pannekoek, A., de Vries, R., Mebius, R.E., and Kazemier, G. (2021). De Novo Carcinoma after Solid Organ Transplantation to Give Insight into Carcinogenesis in General\u2014A Systematic Review and Meta-Analysis. Cancers, 13.","DOI":"10.3390\/cancers13051122"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/6\/1719\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:14:48Z","timestamp":1760105688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/6\/1719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,16]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["jcm13061719"],"URL":"https:\/\/doi.org\/10.3390\/jcm13061719","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,16]]}}}